Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Felix Bongomin1,2,3, Sara Gago4,5,6, Rita O Oladele7,8
1The National Aspergillosis Center, Education and Research Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK. felix.ayoli9@gmail.com.
Abstract:
Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are still a neglected topic by public health authorities even though most deaths from fungal diseases are avoidable. Serious fungal infections occur as a consequence of other health problems including asthma, AIDS, cancer, organ transplantation and corticosteroid therapies. Early accurate diagnosis allows prompt antifungal therapy; however this is often delayed or unavailable leading to death, serious chronic illness or blindness. Recent global estimates have found 3,000,000 cases of chronic pulmonary aspergillosis, ~223,100 cases of cryptococcal meningitis complicating HIV/AIDS, ~700,000 cases of invasive candidiasis, ~500,000 cases of Pneumocystis jirovecii pneumonia, ~250,000 cases of invasive aspergillosis, ~100,000 cases of disseminated histoplasmosis, over 10,000,000 cases of fungal asthma and ~1,000,000 cases of fungal keratitis occur annually. Since 2013, the Leading International Fungal Education (LIFE) portal has facilitated the estimation of the burden of serious fungal infections country by country for over 5.7 billion people (>80% of the world's population). These studies have shown differences in the global burden between countries, within regions of the same country and between at risk populations. Here we interrogate the accuracy of these fungal infection burden estimates in the 43 published papers within the LIFE initiative.
Insights
Fungal diseases cause over 1.5 million deaths annually and are often neglected. This study evaluates the accuracy of global fungal infection burden estimates to improve public health strategies.
Area of Science:
- Mycology
- Infectious Diseases
- Public Health
Background:
- Fungal diseases are a significant global health burden, causing over 1.5 million deaths and affecting over a billion people.
- Despite their impact, fungal infections remain neglected by public health authorities, with many deaths being preventable.
- Serious fungal infections often arise secondary to other conditions like HIV/AIDS, cancer, and immunosuppressive therapies.
Purpose of the Study:
- To assess the accuracy of existing estimates for the global burden of serious fungal infections.
- To evaluate the methodologies used in fungal infection burden studies published under the Leading International Fungal Education (LIFE) initiative.
- To identify potential improvements for future epidemiological assessments of fungal diseases.
Main Methods:
- Systematic review and critical appraisal of 43 published papers from the LIFE initiative.
- Analysis of country-specific and regional estimates of fungal infection prevalence and incidence.
- Interrogation of data collection and statistical methodologies employed in the selected studies.
Main Results:
- The study critically examines the accuracy of fungal infection burden data derived from 43 LIFE initiative publications.
- Significant variations in the global burden of fungal infections were observed between countries and within regions.
- The analysis highlights the need for robust and standardized methodologies in estimating the impact of fungal diseases.
Conclusions:
- Accurate estimation of the burden of serious fungal infections is crucial for effective public health intervention and resource allocation.
- The findings underscore the importance of validating epidemiological data to ensure reliable public health planning for fungal diseases.
- Improving the accuracy of fungal disease burden estimates can help elevate their priority on the global health agenda.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Global Climate Change
National Nursing Organizations I
National Nursing Organizations II
The AACN emphasizes a healthy work environment through six standards to achieve an optimal patient outcome. The standards are appropriate staffing, meaningful recognition, collaboration, authentic leadership, effective communication, and decision-making. In addition, AACN provides certification programs, webinars, journals, and...
Fungal Group Zygomycota
What are Estimates?
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...


